Indefinite Delivery Contract N0018926DB001
Award Date 3/18/26
Last Date to Order 3/17/31
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation based in Fremont, California, has been awarded a single-award Indefinite Delivery Contract by the Navy Bureau of Medicine and Surgery with a ceiling value of $491,914.60 and a performance period extending through October 31, 2029. The contract provides for the supply of DRI Hydrocodone Reagent Kits in 500-milliliter quantities (Part Number: 10018053PSC) to support the Department of Defense Drug Demand...
- Microgenics Corporation, a division of Thermo Electron Corporation's Clinical Diagnostics business, has been awarded multiple firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery. The delivery orders, valued from $4,013 to $34,913.10, are for the provision of DRI-ECSTASY PLUS MDMA/MDA and other reagent kits to support the Bureau's drug testing and identification programs at Navy and Marine Corps medical...
- The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 1 (VISN 1), has awarded a Blanket Purchase Agreement (BPA) to Microgenics Corporation, a subsidiary of Thermo Electron Corporation. The BPA, valued at a ceiling of $450,000.00, is for the provision of toxicology reagents and equipment, including immunoassay reagent test kits, drug screening products, and related laboratory supplies to support substance abuse testing and treatment programs at military medical...
- The U.S. Marine Corps awarded a single-award Indefinite Delivery Contract to Innovative Science LLC (doing business as My Bio Tests) on December 7, 2025, for the supply of drug testing kits. This Total Small Business set-aside contract carries a ceiling value of $1,131,658.00 and extends through December 6, 2030. The contract procures non-instrumental, single-use instant drug test kits for use at Military Entrance Processing Stations to screen poolees and applicants for controlled substances...
- The federal contract IDV award is held by Microgenics Corporation, a subsidiary of Thermo Electron Corporation, and is focused on providing benzodiazepine reagent kits and related clinical diagnostics products to the U.S. Department of Defense and Department of Veterans Affairs. The $5,515,434.90 single-award indefinite delivery contract supports the DoD's Drug Demand Reduction Program by supplying FDA-approved immunoassay reagents and toxicology testing solutions compatible with clinical...
- The Indefinite Delivery Contract (IDC) N0018925DZ006 was awarded to Microgenics Corporation, a manufacturer of clinical diagnostic products and toxicology testing solutions. The $775,453.50 single-award contract was issued by the Navy Bureau of Medicine and Surgery, a defense agency, with a period of performance through January 2030. The purpose of this IDC is to provide the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems with a steady supply of...
- The key elements of the federal contract IDV and associated task orders are as follows: The Department of Defense (DoD) Drug Demand Reduction Program has awarded Microgenics Corporation, a subsidiary of Thermo Electron Corporation, a single-award indefinite delivery contract (IDC) valued at $750,435.30 for the supply of DRI Opiate 500ML Reagent Test Kits. This IDC supports the procurement of FDA-approved immunoassay reagent test kits used to detect substances such as hydrocodone,...
- Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft headquartered in Tarrytown, New York, was awarded a single-award Indefinite Delivery Contract valued at $4.125 million by the Bureau of Medicine and Surgery (BUMED), a defense agency within the Department of the Navy, effective April 1, 2024, through September 30, 2029. The contract procures LSD (lysergic acid diethylamide) reagent kits designated for the Drug Demand Reduction Program (DDRP), which supports the...
- The Department of the Navy Bureau of Medicine and Surgery (BUMED) awarded an Indefinite Delivery Contract (IDC) valued at $825,606.25 to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, to provide amphetamine (AMP) and methamphetamine (METH) reagent kits and associated laboratory diagnostic equipment and services. The contract was awarded on June 17, 2019 without any set-aside designations. Under the IDC, Siemens Healthcare Diagnostics has received multiple firm...
- The Naval Medical Logistics Command awarded an indefinite-delivery contract to Siemens Healthcare Diagnostics Inc. to supply cannabinoid immunoassay reagent kits in support of the Department of Defense Drug Demand Reduction Program. The contract has a five-year ordering period from June 2021 through June 2026 with an estimated value of $750,270. Task orders issued against the contract by various military medical agencies require Siemens to provide the immunoassay kits used to detect cannabinoids...